Stanley D. Chamberlain
Research Triangle Park Foundation(US)GlaxoSmithKline (United States)(US)
Publications by Year
Research Areas
Metabolism, Diabetes, and Cancer, HIV/AIDS drug development and treatment, Cancer, Hypoxia, and Metabolism, Hepatitis C virus research, Growth Hormone and Insulin-like Growth Factors
Most-Cited Works
- → Inhibition of colony-stimulating-factor-1 signalingin vivowith the orally bioavailable cFMS kinase inhibitor GW2580(2005)252 cited
- → Design, Synthesis, and Antiviral Activity of α-Nucleosides: d- and l-Isomers of Lyxofuranosyl- and (5-Deoxylyxofuranosyl)benzimidazoles(1998)211 cited
- → Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus(2010)99 cited
- → GSK1838705A inhibits the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase and shows antitumor activity in experimental models of human cancers(2009)98 cited
- → Pyrazolo[1,5-a]pyridines as p38 Kinase Inhibitors(2005)87 cited
- → INX-08189, a Phosphoramidate Prodrug of 6-O-Methyl-2′-C-Methyl Guanosine, Is a Potent Inhibitor of Hepatitis C Virus Replication with Excellent Pharmacokinetic and Pharmacodynamic Properties(2011)84 cited